202 related articles for article (PubMed ID: 3109729)
1. Effect of prostaglandin E2-producing nonmetastatic Lewis lung carcinoma cells on the migration of prostaglandin E2-responsive metastatic Lewis lung carcinoma cells.
Young MR; Young ME; Wepsic HT
Cancer Res; 1987 Jul; 47(14):3679-83. PubMed ID: 3109729
[TBL] [Abstract][Full Text] [Related]
2. Association of a functional prostaglandin E2-protein kinase A coupling with responsiveness of metastatic Lewis lung carcinoma variants to prostaglandin E2 and to prostaglandin E2-producing nonmetastatic Lewis lung carcinoma variants.
Young MR; Duffie GP; Lozano Y; Young ME; Wright MA
Cancer Res; 1990 May; 50(10):2973-8. PubMed ID: 2159367
[TBL] [Abstract][Full Text] [Related]
3. Relationships between morphology, dissemination, migration, and prostaglandin E2 secretion by cloned variants of Lewis lung carcinoma.
Young MR; Newby M; Meunier J
Cancer Res; 1985 Aug; 45(8):3918-23. PubMed ID: 3860290
[TBL] [Abstract][Full Text] [Related]
4. Association of increased tumor cell responsiveness to prostaglandin E2 with more aggressive tumor behavior.
Young MR; Okada F; Tada M; Hosokawa M; Kobayashi H
Invasion Metastasis; 1991; 11(1):48-57. PubMed ID: 2061004
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E production by Lewis lung carcinoma: mechanism for tumor establishment in vivo.
Young MR; Knies S
J Natl Cancer Inst; 1984 Apr; 72(4):919-22. PubMed ID: 6584667
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 production by EL 4 leukemia cells from C57BL/6 mice: mechanism for tumor dissemination.
Mahan M; Meunier J; Newby M; Young MR
J Natl Cancer Inst; 1985 Jan; 74(1):191-5. PubMed ID: 3855478
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of Lewis lung carcinoma cell migration by prostaglandin E2 produced by macrophages.
Young MR; Newby M
Cancer Res; 1986 Jan; 46(1):160-4. PubMed ID: 3455665
[TBL] [Abstract][Full Text] [Related]
8. Regulation of tumor-induced myelopoiesis and the associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma by prostaglandin E2.
Young MR; Young ME; Kim K
Cancer Res; 1988 Dec; 48(23):6826-31. PubMed ID: 2972359
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of spleen cell cytotoxic capacity toward tumor by elevated prostaglandin E2 levels in mice bearing Lewis lung carcinoma.
Young MR; Hoover CS
J Natl Cancer Inst; 1986 Aug; 77(2):425-9. PubMed ID: 2942724
[TBL] [Abstract][Full Text] [Related]
10. Differential induction of suppressor macrophages by cloned Lewis lung carcinoma variants in mice.
Young MR; Newby M
J Natl Cancer Inst; 1986 Dec; 77(6):1255-60. PubMed ID: 3491925
[TBL] [Abstract][Full Text] [Related]
11. Activation of protein kinase A increases the in vitro invasion, migration, and adherence to reconstituted basement membrane by Lewis lung carcinoma tumor cells.
Young MR; Young ME; Lozano Y; Bagash JM
Invasion Metastasis; 1992; 12(5-6):253-63. PubMed ID: 1298738
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the growth of Lewis lung carcinoma by indomethacin in conventional, nude, and beige mice.
Maca RD
J Biol Response Mod; 1988 Dec; 7(6):568-80. PubMed ID: 3216222
[TBL] [Abstract][Full Text] [Related]
13. Effects of fish oil and corn oil diets on prostaglandin-dependent and myelopoiesis-associated immune suppressor mechanisms of mice bearing metastatic Lewis lung carcinoma tumors.
Young MR; Young ME
Cancer Res; 1989 Apr; 49(8):1931-6. PubMed ID: 2522813
[TBL] [Abstract][Full Text] [Related]
14. Tumoricidal activity of alveolar and peritoneal macrophages of C57BL/6 mice bearing metastatic or nonmetastatic variants of Lewis lung carcinoma.
Duffie GP; Young MR
J Leukoc Biol; 1991 Jan; 49(1):8-14. PubMed ID: 1984486
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory effects of prostaglandin E1 and indomethacin on the growth and metastasis of transplanted Lewis lung carcinoma in C57BL mice.
Tang DG; Tian HS
Chin Med J (Engl); 1990 Mar; 103(3):208-15. PubMed ID: 2164465
[TBL] [Abstract][Full Text] [Related]
16. Changes in VEGF level and tumor growth characteristics during lewis lung carcinoma progression towards cis-DDP resistance.
Pyaskovskaya ON; Dasyukevich OI; Kolesnik DL; Garmanchouk LV; Todor IN; Solyanik GI
Exp Oncol; 2007 Sep; 29(3):197-202. PubMed ID: 18004244
[TBL] [Abstract][Full Text] [Related]
17. In vitro locomotion of allosensitized T lymphocyte clones in response to metabolites of arachidonic acid is subset specific.
Jordan ML; Hoffman RA; Debe EF; Simmons RL
J Immunol; 1986 Jul; 137(2):661-8. PubMed ID: 3013998
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 regulation of tumoristatic factor production by macrophage-like P388D1 cells.
Young MR; Simmermaker JA
J Natl Cancer Inst; 1984 Oct; 73(4):959-62. PubMed ID: 6592390
[TBL] [Abstract][Full Text] [Related]
19. Immunosubversive role of PGE2 in tumor bearing mice.
Ippoliti F; Sezzi ML; Bellelli L; Naso G; Pontieri GM
Boll Ist Sieroter Milan; 1985; 64(1):25-34. PubMed ID: 3859302
[TBL] [Abstract][Full Text] [Related]
20. Regulation of protein kinase A activation and prostaglandin E2-stimulated migration of Lewis lung carcinoma clones.
Young MR; Young ME; Lozano Y; Coogan M; Bagash JM
Int J Cancer; 1991 Aug; 49(1):150-5. PubMed ID: 1651907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]